TS Financial Group (TSFG)’s Anavex Life Sciences AVXL Stock Holding History

TS Financial Group (TSFG)’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Hold	30	–	–	﹤0.01%	847
2026 Q1	$0	Hold	30	–	–	﹤0.01%	815
2025 Q4	$0	Hold	30	–	–	﹤0.01%	811
2025 Q3	$0	Hold	30	–	–	﹤0.01%	824
2025 Q2	$0	Hold	30	–	–	﹤0.01%	800
2025 Q1	$0	Hold	30	–	–	﹤0.01%	798
2024 Q4	$0	Hold	30	–	–	﹤0.01%	741
2024 Q3	$0	Hold	30	–	–	﹤0.01%	771
2024 Q2	$0	Hold	30	–	–	﹤0.01%	757
2024 Q1	$0	Hold	30	–	–	﹤0.01%	765
2023 Q4	$0	Hold	30	–	–	﹤0.01%	884
2023 Q3	$1K	Hold	30	–	–	﹤0.01%	884
2023 Q2	$0	Hold	30	–	–	﹤0.01%	988
2023 Q1	$0	Hold	30	–	–	﹤0.01%	956
2022 Q4	$0	Hold	30	–	–	﹤0.01%	971
2022 Q3	$0	Hold	30	–	–	﹤0.01%	953
2022 Q2	$0	Hold	30	–	–	﹤0.01%	978
2022 Q1	$0	Hold	30	–	–	﹤0.01%	913
2021 Q4	$1K	Hold	30	–	–	﹤0.01%	802
2021 Q3	$1K	Hold	30	–	–	﹤0.01%	785
2021 Q2	$1K	Hold	30	–	–	﹤0.01%	785
2021 Q1	$0	Buy	+30	New	+$328	﹤0.01%	761

Other funds holding AVXL

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

PAM

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

SSWM

Sheets Smith Wealth Management Winston-Salem, North Carolina $1B AUM 29.77% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

LexAurum Advisors Overland Park, Kansas $866M AUM

AHL

Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return

CIC

Carnegie Investment Counsel Pepper Pike, Ohio $4.99B AUM 23.08% 1-Year Est. Return

OCG

Opus Capital Group Cincinnati, Ohio $1.03B AUM 20.67% 1-Year Est. Return

TS Financial Group (TSFG)'s AVXL Position: Q2 2026 in Review

TS Financial Group (TSFG) held its Anavex Life Sciences (AVXL) position steady in Q2 2026 at 30 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #847.

TS Financial Group (TSFG) first reported a position in AVXL in Q1 2021 and has held it in 22 quarters since. The position peaked at $1K in Q3 2023. 40 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

TS Financial Group (TSFG) held 30 shares of Anavex Life Sciences worth $0 as of Q2 2026.
TS Financial Group (TSFG) left its Anavex Life Sciences share count unchanged in Q2 2026.
Anavex Life Sciences made up ﹤0.01% of TS Financial Group (TSFG)'s portfolio in Q2 2026, its #847 holding.
TS Financial Group (TSFG) first reported a position in Anavex Life Sciences in Q1 2021 and has held it in 22 quarters since.
TS Financial Group (TSFG)'s Anavex Life Sciences position peaked at $1K in Q3 2023.
40 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on TS Financial Group (TSFG)'s 13F filing for Q2 2026, filed 23 Jul 2026.